Can we trust India's drug regulator? Dinesh Thakur and Prashant Reddy weigh in episode artwork

EPISODE · Oct 20, 2022 · 23 MIN

Can we trust India's drug regulator? Dinesh Thakur and Prashant Reddy weigh in

from From the bookshelves of Forbes India · host Forbes India

How safe are medicines made in India? Four cough and cold syrups made in India have allegedly caused the death of 66 children in the African nation of Gambia, which the Indian drug regulator is currently investigating. The syrups contained diethylene glycol (DEG) and ethylene glycol, which can be fatal for humans who consume it. India has had a record of at least five major events of poisoning by DEG in the past. In today's episode, Dinesh Thakur and Prashant Reddy, authors of The Truth Pill (published by Simon & Schuster India), speak with Divya Shekhar about the problem with drug regulation in India, how drug regulators are more responsive to pharma companies rather than the people of India, and what adverse events due to substandard drugs mean for the $42 billion pharmaceutical industry in India, which, according to the Economic Survey 2021, is expected to reach $120-$130 million by 2030.

Episode metadata supplied by the publisher feed · Published Oct 20, 2022

Embed this episode

NOW PLAYING

Can we trust India's drug regulator? Dinesh Thakur and Prashant Reddy weigh in

0:00 23:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of From the bookshelves of Forbes India?

This episode is 23 minutes long.

When was this From the bookshelves of Forbes India episode published?

This episode was published on October 20, 2022.

Can I download this From the bookshelves of Forbes India episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!